2023 New York Laws › PBH - Public Health › Article 2-B - Drug Take Back › 290 - Definitions.

§  290.  Definitions.  As  used  in  this  article, unless the context
  clearly requires otherwise:
1. "Authorized collector" means: (a) a person, company, corporation or
  other entity that is registered with the United States Drug  Enforcement
  Administration to collect controlled substances for the purposes of safe
  disposal and destruction; (b) a law enforcement agency; or (c) a person,
  company,  corporation  or  other  entity authorized by the department to
  provide alternative collection methods for covered drugs  that  are  not
  controlled substances.
2.  "Covered  drug"  means any substance recognized as a drug under 21
  USC § 321(g)(1), as amended, and any regulations promulgated  thereunder
  that  is  sold,  offered  for  sale  or  dispensed in the state, whether
  directly or through a wholesaler, in any form including prescription and
  nonprescription  drugs,  drugs  in  medical  devices   and   combination
  products, brand and generic drugs and drugs for veterinary use; provided
  however,  covered  drug  shall not include: (a) vitamins or supplements;
  (b) herbal-based remedies and homeopathic drugs, products  or  remedies;
  (c)  cosmetics,  soap  (with  or  without  germicidal  agents),  laundry
  detergent, bleach, household cleaning  products,  shampoos,  sunscreens,
  toothpaste,  lip  balm,  antiperspirants or other personal care products
  that are regulated as both cosmetics and nonprescription drugs under the
  Federal Food,  Drug,  and  Cosmetic  Act;  (d)  pet  pesticide  products
  contained  in  pet  collars, powders, shampoos, topical applications, or
  other forms; (e) drugs  that  are  biological  products  as  defined  in
  subdivision  twenty-seven  of  section  sixty-eight  hundred  two of the
  education law if the manufacturer already provides a take back  program;
  (f)  drugs for which a manufacturer provides a take back program as part
  of a Federal Food and Drug Administration managed  risk  evaluation  and
  mitigation  strategy;  (g)  emptied injector products or emptied medical
  devices and their component parts or accessories; and (h) drugs that are
  used solely in a clinical setting.
3. "Manufacturer" means a person, company, corporation or other entity
  engaged  in  the  manufacture  of  covered  drugs  sold  in  the  state.
  Manufacturer does not include a repackager or wholesaler.
4.   "Pharmacies"   means  all  pharmacies  registered  under  section
  sixty-eight hundred eight of the education law that are part of a  group
  of ten or more establishments that conduct business under the same name,
  or  operate  under  a  common  ownership or management, or pursuant to a
  franchise agreement  with  the  same  franchisor,  and  all  nonresident
  pharmacies registered pursuant to section sixty-eight hundred eight-b of
  the education law that provide covered drugs to state residents by mail.
5. "Drug take back organization" means an organization designated by a
  manufacturer or a group of manufacturers to act as an agent on behalf of
  the  manufacturer  or  group of manufacturers to operate and implement a
  drug take back program as authorized by this article.
6. "Wholesaler" means any person, company, corporation or other entity
  that sells or distributes drugs and  covered  drugs  for  resale  to  an
  entity in the state other than a consumer.
7. "Repackager" means an entity that owns or operates an establishment
  that repacks and relabels a product or package containing a covered drug
  for further sale or for distribution without further transaction.